178 related articles for article (PubMed ID: 37713468)
21. Targetable signaling pathway mutations are associated with malignant phenotype in IDH-mutant gliomas.
Wakimoto H; Tanaka S; Curry WT; Loebel F; Zhao D; Tateishi K; Chen J; Klofas LK; Lelic N; Kim JC; Dias-Santagata D; Ellisen LW; Borger DR; Fendt SM; Vander Heiden MG; Batchelor TT; Iafrate AJ; Cahill DP; Chi AS
Clin Cancer Res; 2014 Jun; 20(11):2898-909. PubMed ID: 24714777
[TBL] [Abstract][Full Text] [Related]
22. The EEG Ictal-Interictal Continuum-A Metabolic Roar But a Whimper of a Functional Outcome.
Lee JW
Epilepsy Curr; 2019; 19(4):234-236. PubMed ID: 31198061
[TBL] [Abstract][Full Text] [Related]
23. Mutant IDH1 and seizures in patients with glioma.
Chen H; Judkins J; Thomas C; Wu M; Khoury L; Benjamin CG; Pacione D; Golfinos JG; Kumthekar P; Ghamsari F; Chen L; Lein P; Chetkovich DM; Snuderl M; Horbinski C
Neurology; 2017 May; 88(19):1805-1813. PubMed ID: 28404805
[TBL] [Abstract][Full Text] [Related]
24. Genetic risk variants in the CDKN2A/B, RTEL1 and EGFR genes are associated with somatic biomarkers in glioma.
Ghasimi S; Wibom C; Dahlin AM; Brännström T; Golovleva I; Andersson U; Melin B
J Neurooncol; 2016 May; 127(3):483-92. PubMed ID: 26839018
[TBL] [Abstract][Full Text] [Related]
25. Correlation of preoperative seizures with a wide range of tumor molecular markers in gliomas: An analysis of 442 glioma patients from China.
Shen S; Bai Y; Zhang B; Liu T; Yu X; Feng S
Epilepsy Res; 2020 Oct; 166():106430. PubMed ID: 32712511
[TBL] [Abstract][Full Text] [Related]
26. PI3 kinase mutations and mutational load as poor prognostic markers in diffuse glioma patients.
Draaisma K; Wijnenga MM; Weenink B; Gao Y; Smid M; Robe P; van den Bent MJ; French PJ
Acta Neuropathol Commun; 2015 Dec; 3():88. PubMed ID: 26699864
[TBL] [Abstract][Full Text] [Related]
27. IDH1/2 wildtype gliomas grade 2 and 3 with molecular glioblastoma-like profile have a distinct course of epilepsy compared to IDH1/2 wildtype glioblastomas.
van Opijnen MP; Tesileanu CMS; Dirven L; van der Meer PB; Wijnenga MMJ; Vincent AJPE; Broekman MLD; Dubbink HJ; Kros JM; van Duinen SG; Smits M; French PJ; van den Bent MJ; Taphoorn MJB; Koekkoek JAF
Neuro Oncol; 2023 Apr; 25(4):701-709. PubMed ID: 35972438
[TBL] [Abstract][Full Text] [Related]
28. Correlation of genetic alterations by whole-exome sequencing with clinical outcomes of glioblastoma patients from the Lebanese population.
Saadeh FS; Morsi RZ; El-Kurdi A; Nemer G; Mahfouz R; Charafeddine M; Khoury J; Najjar MW; Khoueiry P; Assi HI
PLoS One; 2020; 15(11):e0242793. PubMed ID: 33237934
[TBL] [Abstract][Full Text] [Related]
29. Detection of ATRX and IDH1-R132H immunohistochemistry in the progression of 211 paired gliomas.
Cai J; Zhu P; Zhang C; Li Q; Wang Z; Li G; Wang G; Yang P; Li J; Han B; Jiang C; Sun Y; Jiang T
Oncotarget; 2016 Mar; 7(13):16384-95. PubMed ID: 26918938
[TBL] [Abstract][Full Text] [Related]
30. Subclonal Cancer Driver Mutations Are Prevalent in the Unresected Peritumoral Edema of Adult Diffuse Gliomas.
Underhill HR; Karsy M; Davidson CJ; Hellwig S; Stevenson S; Goold EA; Vincenti S; Sellers DL; Dean C; Harrison BE; Bronner MP; Colman H; Jensen RL
Cancer Res; 2024 Apr; 84(7):1149-1164. PubMed ID: 38270917
[TBL] [Abstract][Full Text] [Related]
31. Characteristics of IDH-mutant gliomas with non-canonical IDH mutation.
Poetsch L; Bronnimann C; Loiseau H; Frénel JS; Siegfried A; Seizeur R; Gauchotte G; Cappellen D; Carpentier C; Figarella-Branger D; Eimer S; Meyronet D; Ducray F;
J Neurooncol; 2021 Jan; 151(2):279-286. PubMed ID: 33205355
[TBL] [Abstract][Full Text] [Related]
32. ATRX status correlates with 11 C-methionine uptake in WHO grade II and III gliomas with IDH1 mutations.
Ogishima T; Tamura K; Kobayashi D; Inaji M; Hayashi S; Tamura R; Nariai T; Ishii K; Maehara T
Brain Tumor Pathol; 2017 Jan; 34(1):20-27. PubMed ID: 28251430
[TBL] [Abstract][Full Text] [Related]
33. Surgery guided with intraoperative electrocorticography in patients with low-grade glioma and refractory seizures.
Yao PS; Zheng SF; Wang F; Kang DZ; Lin YX
J Neurosurg; 2018 Mar; 128(3):840-845. PubMed ID: 28387627
[TBL] [Abstract][Full Text] [Related]
34. Segregation of non-p.R132H mutations in IDH1 in distinct molecular subtypes of glioma.
Gravendeel LA; Kloosterhof NK; Bralten LB; van Marion R; Dubbink HJ; Dinjens W; Bleeker FE; Hoogenraad CC; Michiels E; Kros JM; van den Bent M; Smitt PA; French PJ
Hum Mutat; 2010 Mar; 31(3):E1186-99. PubMed ID: 20077503
[TBL] [Abstract][Full Text] [Related]
35. Development of a Rat Model for Glioma-Related Epilepsy.
Bouckaert C; Germonpré C; Verhoeven J; Chong SA; Jacquin L; Mairet-Coello G; André VM; Leclercq K; Vanhove C; De Vos F; Van den Broecke C; Goethals I; Descamps B; Donche S; Carrette E; Wadman W; Boon P; Vonck K; Raedt R
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32977526
[TBL] [Abstract][Full Text] [Related]
36. Germline Mutations for Novel Candidate Predisposition Genes in Sporadic Schwannomatosis.
Min BJ; Kang YK; Chung YG; Seo ME; Chang KB; Joo MW
Clin Orthop Relat Res; 2020 Nov; 478(11):2442-2450. PubMed ID: 32281771
[TBL] [Abstract][Full Text] [Related]
37. Alternative lengthening of telomeres is the major telomere maintenance mechanism in astrocytoma with isocitrate dehydrogenase 1 mutation.
Ferreira MSV; Sørensen MD; Pusch S; Beier D; Bouillon AS; Kristensen BW; Brümmendorf TH; Beier CP; Beier F
J Neurooncol; 2020 Mar; 147(1):1-14. PubMed ID: 31960234
[TBL] [Abstract][Full Text] [Related]
38. Utility of targeted next-generation sequencing assay to detect 1p/19q co-deletion in formalin-fixed paraffin-embedded glioma specimens.
Pallavajjala A; Haley L; Stinnett V; Adams E; Pallavajjala R; Huang J; Morsberger L; Hardy M; Long P; Gocke CD; Eshleman JR; Rodriguez FJ; Zou YS
Hum Pathol; 2022 Aug; 126():63-76. PubMed ID: 35561840
[TBL] [Abstract][Full Text] [Related]
39. Similarity of lateralized rhythmic delta activity to periodic lateralized epileptiform discharges in critically ill patients.
Gaspard N; Manganas L; Rampal N; Petroff OA; Hirsch LJ
JAMA Neurol; 2013 Oct; 70(10):1288-95. PubMed ID: 23921464
[TBL] [Abstract][Full Text] [Related]
40. Effect of PIK3CA variants on glioma-related epilepsy and response to treatment.
Tobochnik S; Pisano W; Lapinskas E; Ligon KL; Lee JW
Epilepsy Res; 2021 Sep; 175():106681. PubMed ID: 34102393
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
